These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33929598)

  • 1. Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.
    Rossello X; Ferreira JP; Caimari F; Lamiral Z; Sharma A; Mehta C; Bakris G; Cannon CP; White WB; Zannad F
    Clin Res Cardiol; 2021 Oct; 110(10):1612-1624. PubMed ID: 33929598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.
    Verma S; Bain SC; Buse JB; Idorn T; Rasmussen S; Ørsted DD; Nauck MA
    JAMA Cardiol; 2019 Dec; 4(12):1214-1220. PubMed ID: 31721979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study.
    Park SJ; Ha KH; Kim DJ
    Cardiovasc Diabetol; 2020 Nov; 19(1):191. PubMed ID: 33172464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
    Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD
    Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.
    Kawabe A; Yasu T; Morimoto T; Tokushige A; Momomura SI; Sakakura K; Node K; Inoue T; Ueda S;
    ESC Heart Fail; 2021 Oct; 8(5):3748-3759. PubMed ID: 34268904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men.
    Sposato LA; Lam M; Allen B; Shariff SZ; Saposnik G;
    Stroke; 2020 Feb; 51(2):387-394. PubMed ID: 31914883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
    Pitts R; Gunzburger E; Ballantyne CM; Barter PJ; Kallend D; Leiter LA; Leitersdorf E; Nicholls SJ; Shah PK; Tardif JC; Olsson AG; McMurray JJ; Kittelson J; Schwartz GG
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28073769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
    Zannad F; Cannon CP; Cushman WC; Bakris GL; Menon V; Perez AT; Fleck PR; Mehta CR; Kupfer S; Wilson C; Lam H; White WB;
    Lancet; 2015 May; 385(9982):2067-76. PubMed ID: 25765696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).
    Vaduganathan M; White WB; Charytan DM; Morrow DA; Liu Y; Zannad F; Cannon CP; Bakris GL;
    Am J Cardiol; 2019 Feb; 123(3):382-391. PubMed ID: 30477800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis.
    Liu T; Fan Z; Xiao B; He C; Wang S
    Cardiovasc Diabetol; 2024 Mar; 23(1):106. PubMed ID: 38528542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study.
    Nicholls SJ; Schwartz GG; Buhr KA; Ginsberg HN; Johansson JO; Kalantar-Zadeh K; Kulikowski E; Toth PP; Wong N; Sweeney M; Ray KK;
    Cardiovasc Diabetol; 2021 Jan; 20(1):13. PubMed ID: 33413345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gender on relative rates of cardiovascular events in patients with diabetes.
    Angoulvant D; Ducluzeau PH; Renoult-Pierre P; Fauchier G; Herbert J; Semaan C; Bodin A; Bisson A; Fauchier L
    Diabetes Metab; 2021 Sep; 47(5):101226. PubMed ID: 33454437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
    Elharram M; Sharma A; White W; Bakris G; Rossignol P; Mehta C; Ferreira JP; Zannad F
    Am Heart J; 2020 Nov; 229():40-51. PubMed ID: 32916607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndrome.
    Tessitore E; Branca M; Heg D; Nanchen D; Auer R; Räber L; Klingenberg R; Windecker S; Lüscher TF; Carballo S; Matter CM; Gmel G; Mukamal KJ; Rodondi N; Carballo D; Mach F; Gencer B
    Eur J Prev Cardiol; 2024 May; 31(7):845-855. PubMed ID: 37995305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
    Elia E; Bruno F; Crimi G; Wańha W; Leonardi S; Mauro M; Raposeiras Roubin S; Fabris E; Giannino G; Mancone M; Severino P; Truffa A; De Filippo O; Huczek Z; Mazurek M; Gaibazzi N; Ielasi A; Cortese B; Borin A; Núñez-Gil IJ; Marengo G; Melis D; Ugo F; Bianco M; Barbieri L; Marchini F; Desperak P; Morici N; Scaglione M; Gąsior M; Gallone G; Lopiano C; Stefanini G; Campo G; Wojakowski W; Abu-Assi E; Sinagra G; de Ferrari GM; Porto I; D'Ascenzo F
    Int J Cardiol; 2024 Feb; 397():131622. PubMed ID: 38061607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk of death and recurrent cardiovascular events following acute coronary syndromes.
    Gouda P; Savu A; Bainey KR; Kaul P; Welsh RC
    PLoS One; 2021; 16(7):e0254008. PubMed ID: 34197547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes.
    Sarma AA; Braunwald E; Cannon CP; Guo J; Im K; Antman EM; Gibson CM; Newby LK; Giugliano RP; Morrow DA; Wiviott SD; Sabatine MS; O'Donoghue ML
    J Am Coll Cardiol; 2019 Dec; 74(24):3013-3022. PubMed ID: 31865968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events.
    Rosenstock J; Marx N; Neubacher D; Seck T; Patel S; Woerle HJ; Johansen OE
    Cardiovasc Diabetol; 2015 May; 14():57. PubMed ID: 25990013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.